期刊文献+

356例氟喹诺酮类药物不良反应报告分析 被引量:2

原文传递
导出
摘要 为了对临床合理用药提供信息,我们对356例氟喹诺酮类药物不良反应报告进行回顾性分析。结果显示,氟喹诺酮类药物诱发的不良反应涉及8种氟喹诺酮类药物,其中左氧氟沙星引起不良反应最多为167例,占47.6%;40岁以上中老年人不良反应最高,占构成比66.9%;不良反应发生情况多表现为神经系统、消化系统及皮肤过敏反应。提示,本类药物不良反应较高。关注其治疗作用的同时,不可忽视其不良反应,以达到临床用药安全、有效的目的。
出处 《工业卫生与职业病》 CAS CSCD 北大核心 2009年第2期109-110,共2页 Industrial Health and Occupational Diseases
  • 相关文献

参考文献4

二级参考文献33

  • 1谢励明,王振元,叶斌主.75例老年人氟喹诺酮类药物不良反应分析[J].国际医药卫生导报,2004,10(14):132-133. 被引量:9
  • 2金桂兰,唐文,赵美菊.528例药品不良反应报告分析[J].药物流行病学杂志,2004,13(5):247-249. 被引量:140
  • 3[21]Takenouchi T, Sakagawa E, Sugawara M. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones [J]. Antimicrob Agents Chemother, 1999,43(2): 406
  • 4[22]Masuda N, Sakagawa E, Ohya S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa[J]. Antiumicrob Agents Chemother , 1995,39(3) :645
  • 5[23]Lomovskaya O, Lee A, Hoshino K, et al. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,1999,43(6):1340
  • 6[24]Ziha-Zarifi Ⅰ, Llanes C, Kohler T, et al. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-oprM [J]. Antimicrob Agents Chemother, 1999,43(2):287
  • 7[25]Lomovskaya O, Warren M S, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy[J].Antimicrob Agents Chemother, 2001,45(1):105
  • 8[1]Bush K, Jacoby G A, Medeiros A A. A functional classification scheme for β-lactanases and its correlation with molecular structure[J]. Artimicrob Agents Chemother , 1994,39(6): 1211
  • 9[2]Coulton S, Francois Ⅰ. β-Lactamases :targets for drug design [J].Prog Med Chem, 1994,31:298
  • 10[3]Nass T, Livermore D M,Nordmann P. Characterization of an LysR family potein, SemR from Serratia marcessecs S6. its effect on expression of the carbapenem-hydrolyzing β-lactamases Sme-1 and comparison of this regulator with other β-lactamases regulators[J]. Antimicrob Agents Chenother , 1995,39:629

共引文献134

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部